fluoxetine has been researched along with methadone in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (3.45) | 18.7374 |
1990's | 13 (44.83) | 18.2507 |
2000's | 7 (24.14) | 29.6817 |
2010's | 8 (27.59) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Nagashima, R; Nishikawa, T; Tobita, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Freiwald, S; Jiang, Y; Jones, JP; Kaspera, R; Katayama, J; Lee, CA; Smith, E; Totah, RA; Walker, GS | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brooke, D; Fudala, PJ; Johnson, RE | 1 |
Batki, SL; Dumontet, R; Jacob, P; Jones, RT; Manfredi, LB; Sorensen, JL | 1 |
Pollack, MH; Rosenbaum, JF | 1 |
Smith, DF | 1 |
Creson, D; Davis, C; Elk, R; Grabowski, J; Kirby, K; Rhoades, H; Schmitz, J | 1 |
Carroll, K; Cushing, G; Gordon, L; Petrakis, I; Rounsaville, B | 1 |
Balon, R | 1 |
Batki, SL; Jacob, P; Jones, RT; Manfredi, LB | 1 |
Baumann, P; Bertschy, G | 1 |
Baumann, P; Bertschy, G; Eap, CB; Powell, K | 2 |
Berthou, F; Dréano, Y; Iribarne, C; Picart, D | 1 |
Creson, D; Elk, R; Grabowski, J; Hussein, I; Rhoades, HM; Schmitz, JM | 1 |
Carroll, KM; Gordon, L; Kosten, T; Nich, C; Petrakis, I; Rounsaville, B | 1 |
Bell, J; Christie, MJ; Dean, AJ; Mascord, DJ; Parker, G | 1 |
Calleri, E; Cherkaoui, S; Geiser, L; Prat, J; Rudaz, S; Veuthey, JL | 1 |
Haining, RL; Yu, AM | 1 |
Marchi, I; Rudaz, S; Selman, M; Veuthey, JL | 1 |
Greenwald, MK | 1 |
Bigelow, GE; Johnson, RE; Silverman, K; Strain, EC; Winstanley, EL | 1 |
Kukanich, B; Kukanich, KS; Rodriguez, JR | 1 |
Atayee, RS; Best, BM; Luk, S; Ma, JD | 1 |
KuKanich, B; KuKanich, K | 1 |
1 review(s) available for fluoxetine and methadone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
9 trial(s) available for fluoxetine and methadone
Article | Year |
---|---|
Weighing up the pros and cons: help-seeking by drug misusers in Baltimore, USA.
Topics: Adult; Bromocriptine; Buprenorphine; Cocaine; Desipramine; Fear; Female; Fluoxetine; Humans; Male; Methadone; Middle Aged; Motivation; Opioid-Related Disorders; Patient Acceptance of Health Care; Phencyclidine Abuse; Substance Abuse Treatment Centers; Substance-Related Disorders; Urban Population | 1992 |
Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: two placebo-controlled double-blind trials.
Topics: Adult; Cocaine; Demography; Double-Blind Method; Female; Fluoxetine; Humans; Male; Methadone; Opioid-Related Disorders; Psychiatric Status Rating Scales | 1995 |
Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/benzoylecgonine concentrations.
Topics: Adult; Cocaine; Female; Fluoxetine; Humans; Male; Methadone; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Substance-Related Disorders | 1993 |
Medication take-home doses and contingency management.
Topics: Adult; Cocaine-Related Disorders; Female; Fluoxetine; Humans; Male; Methadone; Middle Aged; Opioid-Related Disorders | 1998 |
Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts.
Topics: Adult; Antidepressive Agents, Second-Generation; Behavior, Addictive; Cocaine; Cocaine-Related Disorders; Depression; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Heroin; Humans; Male; Methadone; Narcotics; Opioid-Related Disorders; Substance Abuse Detection; Treatment Outcome | 1998 |
Fluvoxamine and fluoxetine do not interact in the same way with the metabolism of the enantiomers of methadone.
Topics: Fluoxetine; Fluvoxamine; Humans; Methadone; Narcotics; Selective Serotonin Reuptake Inhibitors; Statistics, Nonparametric; Stereoisomerism; Substance-Related Disorders | 1997 |
A randomised, controlled trial of fluoxetine in methadone maintenance patients with depressive symptoms.
Topics: Adult; Antidepressive Agents; Comorbidity; Depression; Female; Fluoxetine; Humans; Male; Methadone; Narcotics; Patient Compliance; Substance-Related Disorders | 2002 |
A randomized controlled trial of fluoxetine in the treatment of cocaine dependence among methadone-maintained patients.
Topics: Adult; Cocaine-Related Disorders; Double-Blind Method; Female; Fluoxetine; Humans; Male; Methadone; Middle Aged; Motivation; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Selective Serotonin Reuptake Inhibitors; Substance Abuse Detection; Time Factors; Token Economy; Treatment Outcome | 2011 |
The effects of concurrent administration of cytochrome P-450 inhibitors on the pharmacokinetics of oral methadone in healthy dogs.
Topics: Administration, Oral; Analgesics, Opioid; Animals; Area Under Curve; Chloramphenicol; Cytochrome P-450 Enzyme Inhibitors; Dogs; Drug Therapy, Combination; Female; Fluoxetine; Ketoconazole; Male; Methadone; Prospective Studies; Trimethoprim | 2011 |
19 other study(ies) available for fluoxetine and methadone
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.
Topics: Amiodarone; Astemizole; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Danazol; Drug Discovery; Drug Interactions; Enzyme Inhibitors; Humans; Hydroxylation; In Vitro Techniques; Methylation; Microsomes, Liver; Models, Biological; Molecular Structure; Substrate Specificity; Tandem Mass Spectrometry; Terfenadine | 2012 |
Fluoxetine for cocaine abuse in methadone patients: preliminary findings.
Topics: Adult; Cocaine; Female; Fluoxetine; Heroin Dependence; Humans; Male; Methadone; Substance-Related Disorders | 1990 |
Fluoxetine treatment of cocaine abuse in heroin addicts.
Topics: Adult; Cocaine; Female; Fluoxetine; Follow-Up Studies; Heroin Dependence; Humans; Male; Methadone; Substance Abuse, Intravenous; Substance-Related Disorders | 1991 |
The stereoselectivity of serotonin uptake in brain tissue and blood platelets: the topography of the serotonin uptake area.
Topics: Alanine; Amphetamine; Aniline Compounds; Animals; Antidepressive Agents; Blood Platelets; Brain; Fluoxetine; Humans; Male; Methadone; Mianserin; Mirtazapine; Morpholines; Naphthalenes; Nefopam; Nomifensine; Paroxetine; Piperidines; Rabbits; Serotonin; Stereoisomerism; Tranylcypromine; Viloxazine; Zimeldine | 1986 |
Fluoxetine treatment for dually diagnosed methadone maintained opioid addicts: a pilot study.
Topics: Adult; Cocaine; Combined Modality Therapy; Comorbidity; Depressive Disorder; Diagnosis, Dual (Psychiatry); Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Methadone; Opioid-Related Disorders; Patient Compliance; Personality Inventory; Psychotherapy; Substance Abuse Detection; Substance-Related Disorders | 1994 |
Fluoxetine for cocaine dependence in methadone maintenance.
Topics: Alcoholism; Cocaine; Dopamine Uptake Inhibitors; Drug Synergism; Fluoxetine; Heroin Dependence; Humans; Methadone; Substance Abuse Detection; Substance-Related Disorders | 1994 |
Vulnerability to fluoxetine-induced indifference syndrome among opiate addicts: a case report.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Fluoxetine; Humans; Male; Methadone; Mood Disorders; Narcotics; Opioid-Related Disorders | 1995 |
Fluoxetine addition to methadone in addicts: pharmacokinetic aspects.
Topics: Adult; Analgesics, Opioid; Antidepressive Agents, Second-Generation; Drug Interactions; Female; Fluoxetine; Fluvoxamine; Humans; Male; Methadone; Mood Disorders; Selective Serotonin Reuptake Inhibitors; Substance-Related Disorders | 1996 |
In vitro interactions between fluoxetine or fluvoxamine and methadone or buprenorphine.
Topics: Buprenorphine; Cytochrome P-450 Enzyme System; Fluoxetine; Fluvoxamine; Humans; In Vitro Techniques; Linear Models; Methadone; Microsomes, Liver; Narcotic Antagonists; Narcotics; Selective Serotonin Reuptake Inhibitors | 1998 |
Infinite enantiomeric resolution of basic compounds using highly sulfated cyclodextrin as chiral selector in capillary electrophoresis.
Topics: Cyclodextrins; Cyclohexanols; Electrophoresis, Capillary; Fluoxetine; Mass Spectrometry; Methadone; Stereoisomerism; Tramadol; Venlafaxine Hydrochloride | 2003 |
Expression, purification, and characterization of mouse CYP2d22.
Topics: Amino Acid Sequence; Animals; Baculoviridae; Cell Line; Cloning, Molecular; Codeine; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Dealkylation; Dextromethorphan; Enzyme Inhibitors; Fluoxetine; Insecta; Ketoconazole; Kinetics; Methadone; Mice; Molecular Sequence Data; Molecular Weight; Quinidine; Sequence Homology, Amino Acid; Substrate Specificity | 2006 |
Evaluation of the influence of protein precipitation prior to on-line SPE-LC-API/MS procedures using multivariate data analysis.
Topics: Alanine; Blood Proteins; Chemical Precipitation; Cholecalciferol; Chromatography, Liquid; Flunitrazepam; Fluoxetine; Mass Spectrometry; Methadone; Multivariate Analysis; Online Systems; Pyrrolidines; Solid Phase Extraction | 2007 |
Behavioral economic analysis of drug preference using multiple choice procedure data.
Topics: Choice Behavior; Economics; Fentanyl; Fluoxetine; Hallucinogens; Humans; Hydromorphone; Injections, Intramuscular; Methadone; Models, Psychological; Motivation; N-Methyl-3,4-methylenedioxyamphetamine; Naltrexone; Narcotics; Psychotropic Drugs; Recreation; Selective Serotonin Reuptake Inhibitors; Substance Abuse, Intravenous; Substance-Related Disorders | 2008 |
Urinary diazepam metabolite distribution in a chronic pain population.
Topics: Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Chronic Pain; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Diazepam; Drug Interactions; Esomeprazole; Female; Fluoxetine; Humans; Male; Methadone; Nordazepam; Oxazepam; Retrospective Studies; Specimen Handling; Temazepam | 2014 |
Chloramphenicol significantly affects the pharmacokinetics of oral methadone in Greyhound dogs.
Topics: Administration, Oral; Analgesics, Opioid; Animals; Chloramphenicol; Cimetidine; Cytochrome P-450 Enzyme Inhibitors; Dogs; Drug Interactions; Female; Fluoxetine; Ketoconazole; Male; Medetomidine; Methadone; Trimethoprim | 2015 |